bay-k-8644 has been researched along with Muscle Contraction in 316 studies
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester: A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.
Bay-K-8644 : A racemate comprising equimolar amounts of (R)- and (S)-Bay-K-8644
methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate : A pentasubstituted dihydropyridine carrying methoxycarbonyl, 2-(trifluoromethyl)phenyl and nitro substituents at positions 3, 4 and 5 respectively as well as two methyl substituents at positions 2 and 6.
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In attempt to characterize tetrandrine on pulmonary hypertension, biological activities induced by a range of mediators implicated in the pathogenesis of pulmonary hypertension were investigated." | 7.71 | Effects of tetrandrine on smooth muscle contraction induced by mediators in pulmonary hypertension. ( Chang, TH; Wang, HL; Zhang, XH, 2002) |
| "In attempt to characterize tetrandrine on pulmonary hypertension, biological activities induced by a range of mediators implicated in the pathogenesis of pulmonary hypertension were investigated." | 3.71 | Effects of tetrandrine on smooth muscle contraction induced by mediators in pulmonary hypertension. ( Chang, TH; Wang, HL; Zhang, XH, 2002) |
| "The hypothesis that Ca2+ channel function is altered during pregnancy was tested by comparing responses to potassium chloride (KCl) and phenylephrine in aortic rings of virgin and term-pregnant rats under the influence of nifedipine and Bay K 8644." | 3.69 | Effects of nifedipine and Bay K 8644 on myotropic responses in aortic rings of pregnant rats. ( Brochu, M; Roy, B; Sicotte, B; St-Louis, J, 1995) |
| "The influence of deuterium oxide (D2O) on calcium-dependent vascular smooth muscle contraction was investigated." | 3.68 | Deuterium oxide reduces agonist and depolarization-induced contraction of rat aortic rings. ( Liepins, A; McWilliam, TM; Rankin, AJ, 1990) |
| "The effects of divalent ionophores (A23187 and ionomycin), Ca2+ channel agonist (BAY K 8644), and protein kinase C (C-kinase) activators [phorbol 12-myristate 13-acetate (PMA), mezerein] on bovine tracheal smooth muscle contraction were investigated." | 3.67 | Activation of tracheal smooth muscle contraction: synergism between Ca2+ and activators of protein kinase C. ( Park, S; Rasmussen, H, 1985) |
| "Cardiac arrhythmias associated with intracellular calcium inhomeostasis are refractory to antiarrhythmic therapy." | 1.46 | Inhibition of late sodium current suppresses calcium-related ventricular arrhythmias by reducing the phosphorylation of CaMK-II and sodium channel expressions. ( Chu, YP; Ding, YS; Huang, SH; Huo, Y; Ren, L; Wang, P; Wei, XH; Wu, L; Yang, QM; Yang, W; Yu, SD, 2017) |
| "Dehydroeffusol is a naturally occurring phenanthrene isolated from Juncus effusus." | 1.40 | Effects of dehydroeffusol on spasmogen-induced contractile responses of rat intestinal smooth muscles. ( Di, F; Huang, J; Li, P; Zhai, H, 2014) |
| " Dose-response analyses revealed a structure-activity relationship where the larger the side-chain the higher the inhibitory potency." | 1.33 | Functional inhibition of intestinal and uterine muscles by non-permeant triphenylethylene derivatives. ( Díaz, M; García Marrero, B; Gómez, T; Marrero-Alonso, J, 2006) |
| "Pretreatment with wortmannin (300 nmol/l), an inhibitor of myosin light chain kinase, decreased both contractility and phosphorylation of myosin light chains in parallel." | 1.32 | Heat-shock response is associated with enhanced contractility of vascular smooth muscle in isolated rat aorta. ( Cho, JW; Kang, BS; Kim, CY; Kim, IK; Kim, YH; Park, TG, 2004) |
| "Ramipril treatment decreased systolic pressure in WKY and SHR, decreased heart weight and heart weight-to-body weight ratio in SHR, and decreased body weight in WKY." | 1.31 | Ramipril treatment alters Ca(2+) and K(+) channels in small mesenteric arteries from Wistar-Kyoto and spontaneously hypertensive rats. ( Cox, RH; Dietz, NJ; Lozinskaya, I; Matsuda, K, 2002) |
| " However, the inhibition of the combined CPA and CCh response was reduced and the dose-response curve of SIN-1 shifted to the right." | 1.30 | Involvement of intracellular Ca2+ stores in inhibitory effects of NO donor SIN-1 and cGMP. ( Allescher, HD; Franck, H; Puschmann, A; Schusdziarra, V; Storr, M, 1998) |
| "Ryanodine inhibited the increase in the maximal rate of rise of [Ca2+]i resulting in abolishment of the correlation between force and the maximal rate of rise of [Ca2+]i." | 1.30 | Tight coupling between the rate of rise of Ca2+ transient and peak twitch contraction in guinea-pig papillary muscle. ( Endoh, M; Hori, M; Karaki, H; Miyamoto, S; Ozaki, H, 1999) |
| "Treatment with ramipril reduced blood pressure and force development in response to Bay K8644 in adult SHRSP, although not to levels of WKY rats, whereas WKY rats were unaffected by treatment." | 1.29 | Angiotensin-converting enzyme inhibition during development alters calcium regulation in adult hypertensive rats. ( Traub, O; Webb, RC, 1993) |
| "Nifedipine was equipotent in inhibiting the tonic response at all times tested, while a marked time-dependency of inhibition toward phasic responses was observed." | 1.29 | A pharmacological analysis of calcium channels involved in phasic and tonic responses of the guinea-pig ureter to high potassium. ( Giuliani, S; Maggi, CA, 1995) |
| "A 3% halothane-induced increase in [Ca2+]cyt was observed in the Ca(2+)-free solution even when the muscle strip was pretreated with a 10(-6)-M dose of ryanodine and a 20-mM dose of caffeine, whereas it was abolished completely after the muscle strip was pretreated with ryanodine, caffeine, and 100 nM norepinephrine." | 1.29 | Effects of halothane and isoflurane on cytosolic calcium ion concentrations and contraction in the vascular smooth muscle of the rat aorta. ( Fujita, S; Namba, H; Namiki, A; Notsuki, E; Tsuchida, H; Yamakage, M, 1993) |
| "To investigate the role of hyperinsulinemia/insulin resistance in vasomotor tone regulation, we studied the effects of vasoactive substances on tension and intracellular free calcium concentration ([Ca2+]i) of aortic smooth muscle derived from rats that were made hyperinsulinemic by insulin infusion and from Zucker obese rats with insulin resistance." | 1.29 | Augmented contractile function and abnormal Ca2+ handling in the aorta of Zucker obese rats with insulin resistance. ( Akishita, M; Han, SZ; Kim, S; Kozaki, K; Orimo, H; Ouchi, Y; Toba, K, 1996) |
| "Isoflurane has a lesser ability than halothane to induce contracture in malignant hyperthermia (MH) muscle in vitro." | 1.28 | Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia. ( Adamantidis, MM; Adnet, PJ; Haudecoeur, G; Imbenotte, M; Krivosic-Horber, RM; Reyford, H, 1992) |
| "Fraxinellone and verapamil were more potent and effective in producing relaxation in 60 mmol/l than in 15 mmol/l K(+)-induced contraction." | 1.28 | Vasorelaxing effect in rat thoracic aorta caused by fraxinellone and dictamine isolated from the Chinese herb Dictamnus dasycarpus Turcz: comparison with cromakalim and Ca2+ channel blockers. ( Huang, TF; Ko, FN; Su, MJ; Teng, CM; Wang, ML; Wu, TS; Yu, SM, 1992) |
| "Effects of Bay K 8644, partial depolarization with high potassium, and nifedipine on the dose-response curves of the rat vas deferens to norepinephrine, methacholine and KCI were investigated in HEPES-buffered physiological salt solution (PSS) with or without 20 mM sodium bicarbonate." | 1.28 | Bicarbonate-dependent action of Bay K 8644 in the smooth muscle of the rat vas deferens. ( Gomi, Y; Suzuki, N, 1990) |
| "Nifedipine blocked this increase as well as 45Ca2+ uptake elicited by NA and K+." | 1.28 | Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators. ( Alonso, MJ; Marín, J; Rico, I; Salaices, M, 1990) |
| "1." | 1.28 | Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues. ( Christ, GJ; Maayani, S; Melman, A; Valcic, M, 1990) |
| "Carbachol was applied at 20 degrees C for 5 min." | 1.28 | Carbachol-induced nonspecific desensitization in guinea-pig ileum. ( Casteels, R; Droogmans, G; Himpens, B, 1991) |
| "The dose-response effects of BAY K 8644 and nifedipine on diaphragmatic contractility were assessed in vitro." | 1.28 | Multiple effects of BAY K 8644 and nifedipine on isolated diaphragmatic fibers in vitro. ( Aubier, M; Pavlovic, D; Viires, N, 1991) |
| "0 nM) on dose-response curves to noradrenaline, histamine, calcium (Ca2+) and potassium (K+) in ring preparations of rabbit basilar artery and central ear artery." | 1.28 | The selective potentiation of noradrenaline-induced tone by Bay K 8644 in the rabbit basilar artery. ( Bevan, JA; Dowd, AL; Germann, P; Laher, I, 1989) |
| " Nifedipine (3 X 10(-7) M) produced a parallel shift to the right of the dose-response curve to BAY-K-8644, whereas 5 X 10(-6)M verapamil markedly reduced the responses evoked by all concentrations of this drug." | 1.27 | The effects of BAY-K-8644 on the contraction of cat middle cerebral and femoral arteries. ( Marin, J; Reviriego, J; Salaices, M; Sanchez-Ferrer, CF, 1985) |
| " BAY K 8644, in either potassium buffer, induced a statistically significant shift to the left in the norepinephrine dose-response curve." | 1.27 | The facilitative actions of Bay K 8644 on norepinephrine and KCl-induced contractures of rabbit aortic rings. ( Babich, M; Piascik, MT, 1986) |
| "Nifedipine was less efficacious in relaxing the contractile response to Bay k 8644 compared to the contractile response to K+ in SHRs femoral arteries." | 1.27 | Contractile effects of Bay k 8644, a dihydropyridine calcium agonist, on isolated femoral arteries from spontaneously hypertensive rats. ( Aoki, K; Asano, M; Matsuda, T, 1986) |
| "Caffeine may inhibit noradrenalineinduced Ca2' release." | 1.27 | Inhibitory effects of caffeine on contractions and calcium movement in vascular and intestinal smooth muscle. ( Ahn, HY; Karaki, H; Urakawa, N, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 107 (33.86) | 18.7374 |
| 1990's | 162 (51.27) | 18.2507 |
| 2000's | 29 (9.18) | 29.6817 |
| 2010's | 16 (5.06) | 24.3611 |
| 2020's | 2 (0.63) | 2.80 |
| Authors | Studies |
|---|---|
| Sunkel, CE | 1 |
| Fau de Casa-Juana, M | 1 |
| Santos, L | 1 |
| García, AG | 1 |
| Artalejo, CR | 1 |
| Villarroya, M | 1 |
| González-Morales, MA | 1 |
| López, MG | 1 |
| Cillero, J | 1 |
| Alonso, S | 1 |
| Glossmann, H | 1 |
| Striessnig, J | 1 |
| Vo, D | 2 |
| Matowe, WC | 2 |
| Ramesh, M | 2 |
| Iqbal, N | 1 |
| Wolowyk, MW | 2 |
| Howlett, SE | 1 |
| Knaus, EE | 2 |
| Akula, MR | 1 |
| Dagnino, L | 1 |
| Li-Kwong-Ken, MC | 1 |
| Trezza, A | 1 |
| Spiga, O | 1 |
| Mugnai, P | 1 |
| Saponara, S | 2 |
| Sgaragli, G | 2 |
| Fusi, F | 3 |
| Wiciński, M | 2 |
| Malinowski, B | 2 |
| Rajewski, P | 1 |
| Szychta, P | 1 |
| Wódkiewicz, E | 1 |
| Walczak, M | 1 |
| Górski, K | 1 |
| Pawlak-Osińska, K | 1 |
| Słupski, M | 2 |
| Wei, XH | 1 |
| Yu, SD | 1 |
| Ren, L | 1 |
| Huang, SH | 1 |
| Yang, QM | 1 |
| Wang, P | 1 |
| Chu, YP | 1 |
| Yang, W | 1 |
| Ding, YS | 1 |
| Huo, Y | 1 |
| Wu, L | 1 |
| Zawieja, SD | 1 |
| Castorena-Gonzalez, JA | 1 |
| Scallan, JP | 1 |
| Davis, MJ | 1 |
| Szadujkis-Szadurska, K | 2 |
| Grzesk, G | 2 |
| Szadujkis-Szadurski, L | 2 |
| Gajdus, M | 2 |
| Di, F | 1 |
| Zhai, H | 1 |
| Li, P | 1 |
| Huang, J | 1 |
| Al Dera, H | 1 |
| Callaghan, BP | 1 |
| Brock, JA | 1 |
| Patejdl, R | 1 |
| Leroux, AC | 1 |
| Noack, T | 3 |
| Vasconcelos, LH | 1 |
| Correia, AC | 1 |
| de Souza, IL | 1 |
| Silva, Mda C | 1 |
| Paredes-Gamero, EJ | 2 |
| Santos, BV | 1 |
| Cavalcante, Fde A | 1 |
| da Silva, BA | 2 |
| Pitake, S | 1 |
| Ochs, RS | 1 |
| Muneer, A | 1 |
| Cellek, S | 1 |
| Ralph, DJ | 1 |
| Minhas, S | 1 |
| Lai, HH | 1 |
| Smith, CP | 1 |
| Munoz, A | 1 |
| Boone, TB | 1 |
| Szigeti, GP | 1 |
| Somogyi, GT | 1 |
| Daniel, EE | 7 |
| Eteraf, T | 1 |
| Sommer, B | 1 |
| Cho, WJ | 1 |
| Elyazbi, A | 1 |
| Han, JH | 2 |
| Lee, MY | 3 |
| Lee, SY | 2 |
| Chang, IH | 1 |
| Kim, HJ | 1 |
| Kim, W | 1 |
| Myung, SC | 3 |
| Chang, GJ | 1 |
| Lin, TP | 1 |
| Ko, YS | 1 |
| Lin, MS | 1 |
| Szadujkis-Szadurski, R | 1 |
| Matusiak, G | 1 |
| Glaza, I | 1 |
| Alvarez, SM | 1 |
| Miner, AS | 1 |
| Browne, BM | 1 |
| Ratz, PH | 5 |
| Park, SH | 1 |
| Kim, TH | 1 |
| Moon, YT | 1 |
| Santos, RF | 1 |
| Martins, IR | 1 |
| Travassos, RA | 1 |
| Tavares, JF | 1 |
| Silva, MS | 1 |
| Ferreira, AT | 1 |
| Nouailhetas, VL | 1 |
| Aboulafia, J | 1 |
| Rigoni, VL | 1 |
| Hibberd, TJ | 1 |
| Zagorodnyuk, VP | 1 |
| Spencer, NJ | 1 |
| Brookes, SJ | 1 |
| Hernandez, JM | 1 |
| Janssen, LJ | 1 |
| Cox, RH | 1 |
| Lozinskaya, I | 1 |
| Matsuda, K | 1 |
| Dietz, NJ | 1 |
| Wang, HL | 1 |
| Zhang, XH | 1 |
| Chang, TH | 1 |
| Yaris, E | 1 |
| Kesim, M | 1 |
| Kadioglu, M | 1 |
| Kalyoncu, NI | 1 |
| Ulku, C | 1 |
| Ozyavuz, R | 1 |
| Frosini, M | 1 |
| Gorelli, B | 1 |
| Kim, IK | 1 |
| Park, TG | 1 |
| Kim, YH | 1 |
| Cho, JW | 1 |
| Kang, BS | 1 |
| Kim, CY | 1 |
| Teixeira, CE | 1 |
| Corrado, AP | 1 |
| De Nucci, G | 3 |
| Antunes, E | 1 |
| Muinuddin, A | 2 |
| Kang, Y | 2 |
| Gaisano, HY | 2 |
| Diamant, NE | 2 |
| Ji, J | 1 |
| Sheu, L | 1 |
| Nakahara, T | 1 |
| Mitani, A | 1 |
| Kubota, Y | 1 |
| Maruko, T | 1 |
| Sakamoto, K | 2 |
| Tanaka, Y | 3 |
| Koike, K | 1 |
| Shigenobu, K | 1 |
| Ishii, K | 1 |
| Boddy, G | 1 |
| Forrest, A | 1 |
| Molleman, A | 1 |
| Parsons, M | 1 |
| Marrero-Alonso, J | 1 |
| García Marrero, B | 1 |
| Gómez, T | 1 |
| Díaz, M | 2 |
| Keum, EM | 1 |
| Park, SY | 1 |
| Kim, SC | 1 |
| Ng, YK | 1 |
| de Groat, WC | 1 |
| Wu, HY | 1 |
| Shen, J | 1 |
| Yip, S | 1 |
| Wang, Z | 1 |
| Wang, W | 1 |
| Xing, D | 1 |
| Du, L | 1 |
| Morelli, A | 1 |
| Squecco, R | 1 |
| Failli, P | 1 |
| Filippi, S | 1 |
| Vignozzi, L | 1 |
| Chavalmane, AK | 1 |
| Fibbi, B | 1 |
| Mancina, R | 1 |
| Luciani, G | 1 |
| Gacci, M | 1 |
| Colli, E | 1 |
| Francini, F | 1 |
| Adorini, L | 1 |
| Maggi, M | 1 |
| Hyland, L | 2 |
| Warnock, P | 2 |
| Docherty, JR | 2 |
| Kanmura, Y | 1 |
| Itoh, T | 1 |
| Kuriyama, H | 1 |
| Su, CM | 2 |
| Swamy, VC | 1 |
| Triggle, DJ | 5 |
| Usowicz, MM | 1 |
| Gigg, M | 1 |
| Jones, LM | 1 |
| Cheung, CW | 1 |
| Hartley, SA | 1 |
| Hirota, K | 2 |
| Zsigmond, EK | 2 |
| Matsuki, A | 2 |
| Rabito, SF | 2 |
| Roy, B | 1 |
| Sicotte, B | 1 |
| Brochu, M | 1 |
| St-Louis, J | 1 |
| Asano, M | 6 |
| Masuzawa-Ito, K | 1 |
| Matsuda, T | 3 |
| Suzuki, Y | 1 |
| Oyama, H | 1 |
| Shibuya, M | 1 |
| Sugita, K | 1 |
| Traub, O | 2 |
| Webb, RC | 4 |
| Hayakawa, M | 1 |
| Ito, KM | 1 |
| Ito, K | 1 |
| Gustafsson, H | 1 |
| Nilsson, H | 1 |
| Okamura, H | 1 |
| Fujitani, B | 1 |
| Furukawa, K | 1 |
| Une, T | 1 |
| Nukuda, T | 1 |
| Komiya, M | 1 |
| Kurokawa, M | 1 |
| Barrios, M | 2 |
| Robles, I | 1 |
| Baeyens, JM | 3 |
| Liu, J | 1 |
| Hill, MA | 1 |
| Meininger, GA | 1 |
| Antonaccio, MJ | 1 |
| Normandin, D | 1 |
| Dehpour, AR | 1 |
| Tajkhorshid, E | 1 |
| Behbahani, NR | 1 |
| Kitamura, N | 1 |
| Ohta, T | 1 |
| Ito, S | 1 |
| Nakazato, Y | 1 |
| Maggi, CA | 8 |
| Giuliani, S | 4 |
| Santicioli, P | 4 |
| Poli, E | 2 |
| Pozzoli, C | 1 |
| Coruzzi, G | 2 |
| Bertaccini, G | 2 |
| Masters, AK | 1 |
| Huddart, H | 2 |
| Hetherington, AM | 1 |
| Watts, SW | 1 |
| Sakai, Y | 1 |
| Inazu, M | 1 |
| Shamoto, A | 1 |
| Zhu, B | 1 |
| Homma, I | 1 |
| Oz, M | 3 |
| Frank, GB | 3 |
| Franck, H | 2 |
| Puschmann, A | 2 |
| Schusdziarra, V | 3 |
| Allescher, HD | 3 |
| Lau, WA | 1 |
| Ventura, S | 1 |
| Jiang, Q | 1 |
| Pennefather, JN | 1 |
| Meini, S | 1 |
| Höppner, CK | 1 |
| Stief, CG | 1 |
| Jonas, U | 1 |
| Mandrek, K | 2 |
| Golenhofen, K | 2 |
| Kato, T | 1 |
| Saito, M | 1 |
| Kondo, A | 1 |
| Pérez Vallina, JR | 1 |
| Cantabrana, B | 2 |
| Hidalgo, A | 3 |
| Barrús, MT | 2 |
| Reviriego, J | 3 |
| Marín, J | 9 |
| Nelson, MT | 3 |
| Cheng, H | 1 |
| Rubart, M | 1 |
| Santana, LF | 1 |
| Bonev, AD | 1 |
| Knot, HJ | 1 |
| Lederer, WJ | 1 |
| Morales, MA | 1 |
| Silva, A | 1 |
| Brito, G | 1 |
| Bustamante, S | 1 |
| Ponce, H | 1 |
| Paeile, C | 1 |
| Fernández, AI | 1 |
| García de Boto, MJ | 2 |
| Gutiérrez, M | 1 |
| Kenny, BA | 1 |
| Fraser, S | 1 |
| Spedding, M | 3 |
| Tsuchida, H | 1 |
| Namba, H | 1 |
| Yamakage, M | 1 |
| Fujita, S | 1 |
| Notsuki, E | 1 |
| Namiki, A | 1 |
| Foster, PS | 1 |
| Denborough, MA | 1 |
| Hagiwara, S | 1 |
| Mitsui, M | 2 |
| Karaki, H | 10 |
| Storm, DS | 1 |
| Ozaki, H | 4 |
| Gerthoffer, WT | 1 |
| Hori, M | 2 |
| Sanders, KM | 3 |
| Publicover, NG | 2 |
| Pichoff, BE | 1 |
| Uyehara, CF | 1 |
| Nakamura, KT | 1 |
| Bourreau, JP | 3 |
| Kwan, CY | 3 |
| Van Overloop, B | 1 |
| Stoclet, JC | 3 |
| Gairard, A | 1 |
| Callahan, PE | 1 |
| Lattanzio, FA | 2 |
| Kadlec, O | 1 |
| Schuurkes, J | 1 |
| Seferna, I | 1 |
| Aleixandre, MA | 1 |
| King, AP | 1 |
| Puerro, M | 1 |
| Ko, FN | 2 |
| Wu, YC | 1 |
| Lu, ST | 1 |
| Teng, CM | 2 |
| Kishi, Y | 1 |
| Watanabe, T | 1 |
| Makita, T | 1 |
| Sakita, S | 1 |
| Watanabe, R | 1 |
| Ashikaga, T | 1 |
| Numano, F | 1 |
| Hernández, MC | 2 |
| Salaices, M | 4 |
| Ponte, A | 1 |
| Alonso, MJ | 3 |
| Sánchez-Ferrer, CF | 4 |
| Rodriguez, J | 1 |
| Ouchi, Y | 1 |
| Han, SZ | 1 |
| Kim, S | 1 |
| Akishita, M | 1 |
| Kozaki, K | 1 |
| Toba, K | 1 |
| Orimo, H | 1 |
| Liu, YA | 1 |
| Ostlund, E | 1 |
| Fried, G | 1 |
| Sato, T | 1 |
| Jinsi, A | 1 |
| Paradise, J | 1 |
| Deth, RC | 1 |
| Shuttleworth, CW | 1 |
| Koh, SD | 1 |
| Bayginov, O | 1 |
| Salomone, S | 1 |
| Dessy, C | 1 |
| Morel, N | 2 |
| Godfraind, T | 3 |
| Petkov, GV | 2 |
| Boev, KK | 2 |
| Yamazawa, T | 1 |
| Takeshima, H | 1 |
| Sakurai, T | 1 |
| Endo, M | 1 |
| Iino, M | 1 |
| Montaño, LM | 1 |
| Barajas-Lopez, C | 1 |
| Oba, T | 3 |
| Koshita, M | 1 |
| Aoki, T | 2 |
| Yamaguchi, M | 3 |
| Mulè, F | 1 |
| Serio, R | 1 |
| Erxleben, C | 1 |
| Rathmayer, W | 1 |
| Miwa, T | 1 |
| Endou, M | 1 |
| Okumura, F | 1 |
| Kageyama, M | 1 |
| Fujita, H | 1 |
| Nakata, K | 1 |
| Shirasawa, E | 1 |
| Ma, L | 1 |
| Robinson, CP | 1 |
| Thadani, U | 1 |
| Patterson, E | 1 |
| Sims, SM | 1 |
| Jiao, Y | 1 |
| Preiksaitis, HG | 1 |
| Shenfeld, OZ | 1 |
| Morgan, CW | 1 |
| Nasu, T | 2 |
| Sasaki, M | 2 |
| Shibata, H | 1 |
| Storr, M | 1 |
| Salapatek, AM | 1 |
| Lam, A | 1 |
| Tiritilli, A | 1 |
| Yan, L | 1 |
| Gong, GX | 1 |
| Tse, J | 1 |
| Scholz, PM | 1 |
| Weiss, HR | 1 |
| Valoti, M | 1 |
| Sgaragli, GP | 1 |
| Hukovic, N | 1 |
| Hadziselimovic, R | 1 |
| Moreau, R | 1 |
| Oberti, F | 1 |
| Lahaye, P | 1 |
| Gadano, A | 1 |
| Cailmail, S | 1 |
| Sogni, P | 1 |
| Cales, P | 1 |
| Lebrec, D | 1 |
| Bell, KL | 1 |
| Kemp, BK | 1 |
| McPherson, GA | 1 |
| Hodgson, WC | 1 |
| Nomura, Y | 2 |
| Taylor, MS | 1 |
| Gao, H | 1 |
| Gardner, JD | 1 |
| Benoit, JN | 1 |
| Rácz, D | 1 |
| Zillikens, S | 1 |
| Forstreuter, P | 1 |
| Nagykáldi, Z | 1 |
| Magyar, K | 1 |
| Török, T | 1 |
| Miyamoto, S | 1 |
| Endoh, M | 1 |
| Ren, J | 1 |
| Jefferson, L | 1 |
| Sowers, JR | 1 |
| Brown, RA | 1 |
| Monterrubio, J | 1 |
| Lizardi, L | 1 |
| Zuazaga, C | 1 |
| Shi, XZ | 1 |
| Sarna, SK | 2 |
| Zavecz, JH | 1 |
| Bueno, O | 1 |
| Maloney, RE | 1 |
| O'Donnell, JM | 1 |
| Roerig, SC | 1 |
| Battarbee, HD | 1 |
| Tchugunova, Y | 1 |
| Dinç, M | 1 |
| Gomez, JP | 1 |
| Ghisdal, P | 1 |
| Gonzalez, A | 1 |
| Masui, H | 1 |
| Wakabayashi, I | 2 |
| Siogawa, K | 1 |
| Koizumi, N | 1 |
| Yang, X | 1 |
| Henson, OW | 1 |
| Qian, YM | 1 |
| Huang, YH | 1 |
| Fick, H | 1 |
| Classen, M | 1 |
| Ben-Harari, RR | 1 |
| Stenner, M | 1 |
| Sutin, KM | 1 |
| Kim, BK | 1 |
| Satoh, T | 1 |
| Moriyama, T | 1 |
| Kuriki, H | 1 |
| Lecchini, S | 1 |
| Marcoli, M | 1 |
| De Ponti, F | 1 |
| Castelletti, CA | 1 |
| Frigo, GM | 1 |
| Diederichs, W | 1 |
| Sroka, J | 1 |
| Graff, J | 1 |
| Zheng, W | 1 |
| Stoltefuss, J | 1 |
| Goldmann, S | 1 |
| Adnet, PJ | 3 |
| Krivosic-Horber, RM | 3 |
| Adamantidis, MM | 3 |
| Haudecoeur, G | 4 |
| Reyford, H | 2 |
| Imbenotte, M | 2 |
| Belis, JA | 2 |
| Curley, RM | 2 |
| Murty, VN | 2 |
| Wagner, CH | 2 |
| Winter, SJ | 2 |
| Rohner, TJ | 2 |
| Guimarães, CL | 1 |
| Rae, GA | 3 |
| Candenas, ML | 1 |
| Naline, E | 4 |
| Sarria, B | 3 |
| Advenier, C | 4 |
| Lydrup, ML | 1 |
| Himpens, B | 2 |
| Droogmans, G | 2 |
| Hellstrand, P | 1 |
| Somlyo, AP | 1 |
| Bollen, BA | 1 |
| McKlveen, RE | 1 |
| Stevenson, JA | 1 |
| Yu, SM | 1 |
| Su, MJ | 1 |
| Wu, TS | 1 |
| Wang, ML | 1 |
| Huang, TF | 1 |
| Nasa, Y | 1 |
| Ichihara, K | 1 |
| Yoshida, R | 1 |
| Abiko, Y | 1 |
| Kamishima, T | 1 |
| Patlak, JB | 1 |
| Encabo, A | 1 |
| Ferrer, M | 1 |
| Villamor, J | 1 |
| Balfagón, G | 1 |
| Fernández-Alfonso, MS | 2 |
| Lu, A | 2 |
| Sargent, CA | 1 |
| Vesterqvist, O | 1 |
| McCullough, JR | 1 |
| Ogletree, ML | 1 |
| Grover, GJ | 1 |
| Yamano, S | 1 |
| Sako, T | 1 |
| Kamata, K | 3 |
| Miyata, N | 3 |
| Kasuya, Y | 3 |
| Moreland, S | 3 |
| Moreland, RS | 3 |
| Finger, K | 1 |
| Förster, B | 1 |
| Valeri, P | 2 |
| Morrone, LA | 2 |
| Pimpinella, G | 1 |
| Romanelli, L | 1 |
| Suzuki, N | 2 |
| Gomi, Y | 2 |
| Martinelli, B | 1 |
| Severini, C | 1 |
| White, RE | 1 |
| Carrier, GO | 1 |
| O'Neill, SK | 1 |
| McKay, DW | 1 |
| Campbell, N | 1 |
| Triggle, CR | 2 |
| Crowley, M | 1 |
| Bolger, GT | 3 |
| Boonen, HC | 1 |
| De Mey, JG | 1 |
| Liard, F | 1 |
| Jaramillo, J | 1 |
| Puybasset, L | 1 |
| Lagente, V | 1 |
| Dainty, IA | 1 |
| Bigaud, M | 1 |
| McGrath, JC | 2 |
| Katsuragi, T | 2 |
| Usune, S | 2 |
| Furukawa, T | 2 |
| Abiru, T | 1 |
| Morita, K | 1 |
| Barrett, EF | 1 |
| Bruner, CA | 1 |
| Rico, I | 2 |
| Abe, M | 1 |
| Morikawa, M | 3 |
| Inoue, M | 1 |
| Tsuboi, M | 1 |
| Calixto, JB | 2 |
| Christ, GJ | 1 |
| Maayani, S | 1 |
| Valcic, M | 1 |
| Melman, A | 1 |
| Worley, JF | 2 |
| Kotlikoff, MI | 1 |
| Reyford, GH | 1 |
| Cordonnier, C | 2 |
| Morcillo, E | 1 |
| Cortijo, J | 1 |
| Esplugues, J | 1 |
| Biguad, M | 1 |
| Julou-Schaeffer, G | 1 |
| Parratt, JR | 1 |
| Kakishita, E | 1 |
| Skärby, TV | 1 |
| Högestätt, ED | 2 |
| McWilliam, TM | 1 |
| Liepins, A | 1 |
| Rankin, AJ | 1 |
| Stevens, RJ | 1 |
| Blondfield, DP | 1 |
| Sakata, K | 1 |
| Shibata, S | 4 |
| Satake, N | 4 |
| Kown, SC | 1 |
| Kurahashi, K | 1 |
| Sawada, T | 1 |
| Kodama, I | 1 |
| Shoji, T | 1 |
| Goto, K | 1 |
| Adams, BA | 1 |
| Beam, KG | 1 |
| Geppetti, P | 1 |
| Del Bianco, E | 1 |
| Patacchini, R | 2 |
| Tramontana, M | 1 |
| Abela, AP | 1 |
| Williams, JH | 3 |
| Holland, M | 2 |
| Lee, JC | 2 |
| Ward, CW | 3 |
| McGrath, CJ | 1 |
| Davy, KP | 1 |
| Casteels, R | 1 |
| Wright, G | 1 |
| Viires, N | 1 |
| Pavlovic, D | 1 |
| Aubier, M | 1 |
| Milusheva, E | 1 |
| Boev, K | 1 |
| Papasova, M | 1 |
| Werner, G | 1 |
| Addicks, K | 1 |
| Fricke, U | 1 |
| Klaus, W | 1 |
| Sarram, M | 1 |
| Gielen, W | 1 |
| Bois, P | 1 |
| Romey, G | 1 |
| Lazdunski, M | 2 |
| Claeson, P | 1 |
| Zygmunt, P | 1 |
| Savineau, JP | 1 |
| Marthan, R | 4 |
| Crevel, H | 1 |
| Xu, SF | 1 |
| Collins, MA | 1 |
| Chang, KJ | 1 |
| Nakayama, K | 2 |
| Ishigai, Y | 1 |
| Uchida, H | 1 |
| Dube, GP | 1 |
| Baik, YH | 1 |
| Vaghy, PL | 1 |
| Schwartz, A | 1 |
| Ildefonse, M | 1 |
| Jacquemond, V | 2 |
| Rougier, O | 2 |
| Renaud, JF | 1 |
| Fosset, M | 1 |
| Cheung, DW | 2 |
| Mikkelsen, E | 2 |
| Böhm, M | 1 |
| Burmann, H | 1 |
| Meyer, W | 1 |
| Nose, M | 1 |
| Schmitz, W | 1 |
| Scholz, H | 1 |
| Gopalakrishnan, V | 1 |
| Park, LE | 1 |
| Preuss, KC | 1 |
| Gross, GJ | 1 |
| Brooks, HL | 1 |
| Warltier, DC | 1 |
| Lee, CM | 1 |
| Allen, SL | 1 |
| Foster, RW | 1 |
| Small, RC | 1 |
| Towart, R | 1 |
| Forder, J | 1 |
| Scriabine, A | 1 |
| Rasmussen, H | 3 |
| Park, S | 1 |
| Mikkelsen, EO | 2 |
| Nyborg, NC | 3 |
| Jakobsen, P | 1 |
| Matsuo, K | 2 |
| Uchida, S | 1 |
| Piascik, MT | 1 |
| Babich, M | 1 |
| Aoki, K | 2 |
| Renier, A | 1 |
| MacKay, MJ | 1 |
| Lograno, M | 1 |
| De Luca, A | 1 |
| Persichella, M | 1 |
| Conte-Camerino, D | 1 |
| Donoso, MV | 1 |
| Huidobro-Toro, JP | 1 |
| Kullak, A | 1 |
| Kozlowski, R | 1 |
| Ehrhard, P | 1 |
| Fischli, W | 1 |
| Osterrieder, W | 1 |
| Holck, M | 1 |
| Roy, F | 1 |
| Pruneau, D | 1 |
| Wei, XY | 2 |
| Luchowski, EM | 1 |
| Rutledge, A | 1 |
| Armour, CL | 3 |
| Johnson, PR | 3 |
| Black, JL | 3 |
| Tung, LH | 1 |
| Rand, MJ | 1 |
| Louis, WJ | 1 |
| Fovaeus, M | 2 |
| Andersson, KE | 2 |
| Batra, S | 1 |
| Morgan, E | 1 |
| Sjögren, C | 2 |
| Rampe, D | 1 |
| Sulpizio, A | 1 |
| Hieble, JP | 1 |
| Ebeigbe, AB | 1 |
| Aloamaka, CP | 1 |
| Perlmutter, B | 1 |
| Kennedy, RH | 1 |
| Seifen, E | 1 |
| Soulsby, M | 1 |
| Takuwa, Y | 1 |
| Hudspith, MJ | 1 |
| Brennan, CH | 1 |
| Charles, S | 1 |
| Littleton, JM | 1 |
| Takata, Y | 1 |
| Kato, H | 1 |
| Traoré, F | 1 |
| Cognard, C | 1 |
| Potreau, D | 1 |
| Raymond, G | 1 |
| Uchida, MK | 1 |
| Agrawal, DK | 1 |
| McNeill, JH | 1 |
| Warbanow, W | 2 |
| Will-Shahab, L | 2 |
| Litten, RZ | 1 |
| Suba, EA | 1 |
| Roth, BL | 1 |
| Costa, G | 1 |
| Ahn, HY | 1 |
| Urakawa, N | 1 |
| Singh, YN | 1 |
| Dryden, WF | 1 |
| Black, J | 1 |
| Armour, C | 1 |
| Johnson, P | 1 |
| Sato, K | 1 |
| Dulhunty, AF | 1 |
| Gage, PW | 1 |
| Huang, BS | 2 |
| McCumbee, WD | 2 |
| Wright, GL | 2 |
| Obianime, AW | 1 |
| Hirst, SJ | 1 |
| Dale, MM | 1 |
| Auguet, M | 2 |
| Delaflotte, S | 2 |
| Chabrier, PE | 1 |
| Pirotzky, E | 2 |
| Clostre, F | 2 |
| Braquet, P | 2 |
| Hai, CM | 1 |
| Murphy, RA | 1 |
| Andersson, PO | 1 |
| Malmgren, A | 1 |
| Andriantsitohaina, R | 1 |
| Langton, PD | 1 |
| Hertle, L | 1 |
| Nawrath, H | 1 |
| MacLennan, SJ | 1 |
| Whittle, MJ | 1 |
| Silberberg, SD | 1 |
| Poder, TC | 1 |
| Lacerda, AE | 1 |
| Ito, M | 2 |
| Ohe, M | 1 |
| Ogata, M | 1 |
| Shirato, K | 1 |
| Takishima, T | 1 |
| Newman, AH | 1 |
| Rice, KC | 1 |
| Lueddens, HW | 1 |
| Basile, AS | 1 |
| Skolnick, P | 1 |
| Kashiwabara, T | 1 |
| Yamada, S | 1 |
| Hashimoto, H | 1 |
| Yanagisawa, T | 1 |
| Taira, N | 1 |
| D'Orleans-Juste, P | 2 |
| Finet, M | 1 |
| Vane, JR | 2 |
| Stasch, JP | 1 |
| Kazda, S | 2 |
| Alfredson, M | 1 |
| Howl, JD | 1 |
| Publicover, SJ | 1 |
| Douglas, SA | 1 |
| Bowmer, CJ | 1 |
| Yates, MS | 1 |
| Bournaud, R | 1 |
| Shimahara, T | 1 |
| Garcia, L | 1 |
| Rieger, F | 1 |
| Gotoh, Y | 1 |
| Kumadani, S | 1 |
| Kawai, T | 1 |
| Imaizumi, Y | 1 |
| Watanabe, M | 1 |
| Turner, NC | 1 |
| Power, RF | 1 |
| Polak, JM | 1 |
| Bloom, SR | 1 |
| Dollery, CT | 1 |
| Wilde, DW | 1 |
| Lee, KS | 1 |
| Laher, I | 2 |
| Germann, P | 1 |
| Dowd, AL | 2 |
| Bevan, JA | 2 |
| Vorkapic, P | 1 |
| Turini, D | 1 |
| Barbanti, G | 1 |
| Giachetti, A | 1 |
| Meli, A | 1 |
| Adnet, P | 1 |
| Adamantidis, M | 1 |
| Krivosic-Horber, R | 1 |
| Hashimoto, M | 1 |
| Masumura, S | 1 |
| Abe, K | 1 |
| Saito, H | 1 |
| Matsuki, N | 1 |
| Lawson, K | 2 |
| Cavero, I | 2 |
| García, J | 1 |
| Amador, M | 1 |
| Stefani, E | 1 |
| Del Pozo, E | 1 |
| Chang, CC | 1 |
| Chiou, LC | 1 |
| Hwang, LL | 1 |
| Hong, SJ | 1 |
| Huang, CY | 1 |
| Molderings, GJ | 1 |
| Schümann, HJ | 1 |
| Egleme, C | 1 |
| Al Osachie, I | 1 |
3 reviews available for bay-k-8644 and Muscle Contraction
| Article | Year |
|---|---|
Molecular properties of calcium channels.
Topics: Amino Acid Sequence; Animals; Base Sequence; Calcium Channels; Cloning, Molecular; DNA; Humans; Mode | 1990 |
Slow channel calcium activators, a new group of pharmacological agents.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Calcium channels in smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
313 other studies available for bay-k-8644 and Muscle Contraction
| Article | Year |
|---|---|
Synthesis of 3-[(2,3-dihydro-1,1,3-trioxo-1,2-benzisothiazol-2-yl)alkyl] 1,4-dihydropyridine-3,5-dicarboxylate derivatives as calcium channel modulators.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Gui | 1998 |
Functional, electrophysiology, and molecular dynamics analysis of quercetin-induced contraction of rat vascular musculature.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2022 |
Resveratrol's Impact on Vascular Smooth Muscle Cells Hyporeactivity: The Role of Rho-Kinase Inhibition.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2020 |
Inhibition of late sodium current suppresses calcium-related ventricular arrhythmias by reducing the phosphorylation of CaMK-II and sodium channel expressions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2017 |
Differences in L-type Ca
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2018 |
Role of endothelium, acetylocholine and calcium ions in Bay K8644- and KCl-induced contraction.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2013 |
Effects of dehydroeffusol on spasmogen-induced contractile responses of rat intestinal smooth muscles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2014 |
Modified cytoplasmic Ca2+ sequestration contributes to spinal cord injury-induced augmentation of nerve-evoked contractions in the rat tail artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2014 |
Phenytoin inhibits contractions of rat gastrointestinal and portal vein smooth muscle by inhibiting calcium entry.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2015 |
Flavonoid galetin 3,6-dimethyl ether attenuates guinea pig ileum contraction through K(+) channel activation and decrease in cytosolic calcium concentration.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2015 |
Membrane depolarization increases ryanodine sensitivity to Ca2+ release to the cytosol in L6 skeletal muscle cells: Implications for excitation-contraction coupling.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2016 |
The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapism.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2008 |
Activation of cholinergic receptors blocks non-adrenergic non-cholinergic contractions in the rat urinary bladder.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2008 |
The role of caveolae and caveolin 1 in calcium handling in pacing and contraction of mouse intestine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2009 |
Effect of low concentrations of hydrogen peroxide on the contractile responses of rat detrusor smooth muscle strips.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2010 |
Endothelium-dependent and -independent vasorelaxation induced by CIJ-3-2F, a novel benzyl-furoquinoline with antiarrhythmic action, in rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2010 |
The role of calcium in modulating the reactivity of the smooth muscle cells during ischemia/reperfusion. Part 1.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2010 |
Failure of Bay K 8644 to induce RhoA kinase-dependent calcium sensitization in rabbit blood vessels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2010 |
NS-398 (a selective cyclooxygenase-2 inhibitor) decreases agonist-induced contraction of the human ureter via calcium channel inhibition.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2010 |
Ent-7α-acetoxytrachyloban-18-oic acid and ent-7α-hydroxytrachyloban-18-oic acid from Xylopia langsdorfiana A. St-Hil. & Tul. modulate K(+) and Ca(2+) channels to reduce cytosolic calcium concentration on guinea pig ileum.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2012 |
Identification and mechanosensitivity of viscerofugal neurons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2012 |
L-type Ca(2+) channels, Ca(2+)-induced Ca(2+) release, and BK(Ca) channels in airway stretch-induced contraction.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2012 |
Ramipril treatment alters Ca(2+) and K(+) channels in small mesenteric arteries from Wistar-Kyoto and spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2002 |
Effects of tetrandrine on smooth muscle contraction induced by mediators in pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-d | 2002 |
The effects of paroxetine on rat isolated vas deferens.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2003 |
L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2003 |
Heat-shock response is associated with enhanced contractility of vascular smooth muscle in isolated rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2004 |
Role of Ca2+ in vascular smooth muscle contractions induced by Phoneutria nigriventer spider venom.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2004 |
Regional differences in L-type Ca2+ channel expression in feline lower esophageal sphincter.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2004 |
L-type Ca(2+) channel expression along feline smooth muscle oesophagus.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2004 |
MaxiK channel-triggered negative feedback system is preserved in the urinary bladder smooth muscle from streptozotocin-induced diabetic rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2004 |
Role of l-Ca(2+) channels in intestinal pacing in wild-type and W/W(V) mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2005 |
The responses to manipulation of extracellular and intracellular calcium are altered in the streptozotocin-diabetic rat colon and ileum.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2005 |
Functional inhibition of intestinal and uterine muscles by non-permeant triphenylethylene derivatives.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2006 |
Vasomotor action of insulin on the rabbit normal cavernous smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2006 |
Muscarinic regulation of neonatal rat bladder spontaneous contractions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2006 |
Application of Fourier linear spectral analyses to the characterization of smooth muscle contractile signals.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2007 |
Brazilein-induced contraction of rat arterial smooth muscle involves activation of Ca2+ entry and ROK, ERK pathways.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2008 |
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2008 |
An investigation of the actions of the calcium entry facilitator Bay K 8644 on the rat vas deferens.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1984 |
Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1984 |
Calcium channel activation in vascular smooth muscle by BAY K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1984 |
Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Ketamine inhibits contractile responses of intestinal smooth muscle by decreasing the influx of calcium through the L-type calcium channel.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Effects of nifedipine and Bay K 8644 on myotropic responses in aortic rings of pregnant rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Functional role of charybdotoxin-sensitive K+ channels in the resting state of cerebral, coronary and mesenteric arteries of the dog.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Angiotensin-converting enzyme inhibition during development alters calcium regulation in adult hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Increased resting Ca2+ maintains the myogenic tone and activates K+ channels in arteries from young spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Rhythmic contractions of isolated small arteries from rat: role of calcium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Pharmacologic properties of a novel Ca2+ entry blocker, AJ-2615, in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Mechanisms of myogenic enhancement by norepinephrine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Role of Ca2+ in the vascular contraction caused by a thrombin receptor activating peptide.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
The role of calcium and alpha-adrenoceptors in contractile response of chick expansor secundariorum muscle to field stimulation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Effects of nifedipine and Bay K 8644 on contractile activities in single skeletal muscle fibers of the frog.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Effect of Bay K 8644 and ryanodine on the refractory period, action potential and mechanical response of the guinea-pig ureter to electrical stimulation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Signal transducing mechanisms coupled to histamine H3 receptors and alpha-2 adrenoceptors in the guinea pig duodenum: possible involvement of N-type Ca++ channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Actions of abscisic acid and the analogue SD217595 on calcium mediated activity of rat vas deferens smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
A thiorphan-sensitive mechanism regulates the action of both exogenous and endogenous calcitonin gene-related peptide (CGRP) in the guinea-pig ureter.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Effects of ramipril on contractile oscillations in arteries from genetically hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Contractile hyperreactivity and alteration of PKC activity in gastric fundus smooth muscle of diabetic rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5 | 1994 |
Effect of the calcium channel agonist Bay K8644 on mechanical and electrical responses of frog skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Functional evidence for a glibenclamide-sensitive K+ channel in rat ileal smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Endothelin-induced facilitation of sympathetic neurotransmission to the rat vas deferens: effects of suramin.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Propagation of impulses in the guinea-pig ureter and its blockade by calcitonin gene-related peptide (CGRP).
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Rabbit penile corpus cavernosum: electrical and mechanical activity of isolated strips.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
A pharmacological analysis of calcium channels involved in phasic and tonic responses of the guinea-pig ureter to high potassium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Effects of magnesium ions on detrusor contraction in rat.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Calcium-and G-protein-related spasmolytic effects of nonsteroidal anti-inflammatory drugs on rat uterus contractions in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Effect of Ca2+ agonist Bay K 8644 in human placental arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Relaxation of arterial smooth muscle by calcium sparks.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Vasorelaxant effect of the analgesic clonixin on rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Influence of hormonal status in relaxant effect of diethylstilbestrol and nifedipine on isolated rat uterus contraction.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Effects of halothane and isoflurane on cytosolic calcium ion concentrations and contraction in the vascular smooth muscle of the rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Effects of felodipine, nifedipine and verapamil on cytosolic Ca2+ and contraction in vascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Contractile responses to Bay K 8644 in rats with coarctation-induced hypertension.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Ca2+ regulation of the contractile apparatus in canine gastric smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Effect of calcium agonists, BAY K 8644 and CGP 28392, on guinea pig airway smooth muscle function during development.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Distinct pathways to refill ACh-sensitive internal Ca2+ stores in canine airway smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Age, endothelium and aortic reactivity to calcium in Wistar rat.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Ketamine relaxes rabbit femoral arteries by reducing [Ca2+]i and phospholipase C activity.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
The topographical basis and frequency-dependence in the effect of different compounds on neurogenic contractions of the guinea-pig ileum.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Effect of TMB-8 on alpha-adrenoceptor agonist and KC1 induced-contractions in isolated rabbit aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Ca(2+)-channel blockade in rat thoracic aorta by crychine isolated from Cryptocarya chinensis Hemsl.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Effect of nifedipine on cyclic GMP turnover in cultured coronary smooth muscle cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Effects of Bay K 8644 in aorta from spontaneously hypertensive and Wistar Kyoto rats of different ages.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Mechanisms involved in the relaxant effect of estrogens on rat aorta strips.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
Augmented contractile function and abnormal Ca2+ handling in the aorta of Zucker obese rats with insulin resistance.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
Endothelin-induced contractions in human placental blood vessels are enhanced in intrauterine growth retardation, and modulated by agents that regulate levels of intracellular calcium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
Relaxant effect of ketamine and its isomers on histamine-induced contraction of tracheal smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
A tyrosine kinase regulates alpha-adrenoceptor-stimulated contraction and phospholipase D activation in the rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
Activation of delayed rectifier potassium channels in canine proximal colon by vasoactive intestinal peptide.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
Inhibition by bosentan, an endothelin antagonist, of the hypersensitivity to Ca2+ channel activator evoked by salt-loading in basilar artery of stroke-prone spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
The role of sarcoplasmic reticulum and sarcoplasmic reticulum Ca2+-ATPase in the smooth muscle tone of the cat gastric fundus.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
Subtype specificity of the ryanodine receptor for Ca2+ signal amplification in excitation-contraction coupling.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
Canine bronchial sustained contraction in Ca2+-free medium: role of intracellular Ca2+.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
BAY K 8644 and ClO4- potentiate caffeine contracture without Ca2+ release channel activation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
Mode and mechanism of neurotensin action in rat proximal colon.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
A dihydropyridine-sensitive voltage-dependent calcium channel in the sarcolemmal membrane of crustacean muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
Frequency-dependent effects of Bay K 8644 on tetanic contractions of frog skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
Prostaglandin E1 potentiation of the spontaneous phasic contraction of rat isolated portal vein by a cyclopiazonic acid-sensitive mechanism.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
Involvement of both L- and N-type voltage-dependent Ca2+ channels in KCl- and veratridine-evoked transmitter release from non-adrenergic, non-cholinergic nerves in the rabbit iris sphincter muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
Pharmacological modulation of electromechanical coupling in the proximal and distal regions of the guinea-pig renal pelvis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
Effect of 17-beta estradiol in the rabbit: endothelium-dependent and -independent mechanisms of vascular relaxation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
Regulation of intracellular calcium in human esophageal smooth muscles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
Bethanechol activates a post-receptor negative feedback mechanism in rabbit urinary bladder smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
Long-lasting actions of Bay K 8644 on responses of guinea pig taenia coli.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
Contractile action of Mn2+ via Ca2+ channels activated by bay K 8644 in guinea-pig taenia coli.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
Involvement of intracellular Ca2+ stores in inhibitory effects of NO donor SIN-1 and cGMP.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
Calcium source diversity in canine lower esophageal sphincter muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
Effects of magnesium on human umbilical arteries: role of intracellular calcium stores.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
Relationship between decreased function and O2 consumption caused by cyclic GMP in cardiac myocytes and L-type calcium channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
Myorelaxant activity of 2-t-butyl-4-methoxyphenol (BHA) in guinea pig gastric fundus.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
Endothelin 1 action on isolated rat stomach and the role of calcium ions in ET 1 induced depolarization of smooth muscle cells BC3H1.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1998 |
The smooth muscle relaxant effects of venom from the inland taipan (Oxyuranus microlepidotus).
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1999 |
Ca2+ buffering action of sarcoplasmic reticulum on Bay k 8644-induced Ca2+ influx in rat femoral arterial smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1999 |
Effects of IBMX on norepinephrine-induced vasoconstriction in small mesenteric arteries.
Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifl | 1999 |
[Pre- and postsynaptic action of the ATP-dependent K+-channel-(K+ATP)-opener pinacidil in rabbit pulmonary artery].
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1999 |
Tight coupling between the rate of rise of Ca2+ transient and peak twitch contraction in guinea-pig papillary muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1999 |
Influence of age on contractile response to insulin-like growth factor 1 in ventricular myocytes from spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1999 |
Silent calcium channels in skeletal muscle fibers of the crustacean Atya lanipes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2000 |
Impairment of Ca(2+) mobilization in circular muscle cells of the inflamed colon.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2000 |
Cardiac excitation-contraction coupling in the portal hypertensive rat.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2000 |
Effects of (+) and (-) enantiomers of calcium channel agonist, Bay K 8644, on mechanical and electrical responses of frog skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2000 |
Changes of the potassium currents in rat aortic smooth muscle cells during postnatal development.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2000 |
Neural regulation of in vitro giant contractions in the rat colon.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2001 |
Calcium buffering of resting, voltage-dependent Ca2+ influx by sarcoplasmic reticulum in femoral arteries from spontaneously hypertensive rats at prehypertensive stage.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2001 |
Diminished inibitory action of ethanol on the contraction of gallbladder isolated from chronically ethanol-fed Guinea pigs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2002 |
Smooth muscle in the annulus fibrosus of the tympanic membrane: physiological effects on sound transmission in the gerbil.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2002 |
Inhibitory effects of tetrandrine on Bay k 8644-stimulated contraction of isolated rabbit aortic strips.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Mechanisms of neurotensin-induced inhibition in rat ileal smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Clinical potency of calcium channel blockers in asthma may be related to their inhibition of receptor-mediated phasic responses in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
The long-term inhibitory effect of a Ca2+ channel blocker, nisoldipine, on cytosolic Ca2+ and contraction in vascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Calcium channel blocker-like action of reserpine in smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Selectivity of Ca2+ channel blockers in inhibiting muscular and nerve activities in isolated colon.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Comparison of Bay K 8644, nitrendipine and atropine on spontaneous and pelvic-nerve-induced bladder contractions on rat bladder in vivo.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
L-type Ca2+ channel desensitization by F- reduces PhE-induced increase in [Ca2+]i but not stress.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Calcium channel agonist/antagonist effects on cholinergic stimulation of the diabetic rat bladder.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Dual effects of endothelins -1, -2 and -3 on guinea pig field-stimulated ileum: possible mediation by two receptors coupled to pertussis toxin-insensitive mechanisms.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Effect of epithelium removal and of enkephalin inhibition on the bronchoconstrictor response to three endothelins of the human isolated bronchus.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Paradoxical decrease in cytosolic calcium with increasing depolarization by potassium in guinea-pig mesotubarium smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Halothane relaxes preconstricted small and medium isolated porcine coronary artery segments more than isoflurane.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Vasorelaxing effect in rat thoracic aorta caused by fraxinellone and dictamine isolated from the Chinese herb Dictamnus dasycarpus Turcz: comparison with cromakalim and Ca2+ channel blockers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Carbachol modulates voltage sensitivity of calcium channels in bronchial smooth muscle of rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Vasoconstrictive responses elicited by endothelin in bovine cerebral arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Na+/Ca2+ exchange mediation in the ouabain-induced contraction in human placental vessels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Partial inhibition of skeletal muscle contraction by dantrolene sodium and its modification with perchlorate and Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Excitation-contraction coupling in canine tracheal smooth muscle cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Silver-induced frog skeletal muscle contraction and its modulation by calcium antagonists nifedipine and felodipine and calcium agonist Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Effects of endothelin on the portal vein from spontaneously hypertensive and Wistar Kyoto rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Effects of calcium channel activators on contractile behavior in vascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Light-induced relaxation of smooth muscle after treatment with BAY K 8644 is related to release of nitric oxide.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Some pharmacological characteristics of the guinea pig ileum opioid system activated by cholecystokinin.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Bicarbonate-dependent action of Bay K 8644 in the smooth muscle of the rat vas deferens.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Reproducible withdrawal contractions of isolated guinea-pig ileum after brief morphine exposure: effects of clonidine and nifedipine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Increased calcium sensitivity in isolated resistance arteries from spontaneously hypertensive rats: effects of dihydropyridines.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Tissue selectivity and calcium dependence of contractile responses to endothelin.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Interactions of palmitoyl carnitine with the endothelium in rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Antagonism by nifedipine of contraction and Ca2(+)-influx evoked by ATP in guinea-pig urinary bladder.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Differences in vascular responses to vasoactive agents of basilar artery and aorta from rabbits with alloxan-induced diabetes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Evidence for two calcium-dependent potassium conductances in lizard motor nerve terminals.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Dihydropyridine calcium channel antagonists block and agonists potentiate high potassium contractures but not twitches in frog skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Increased vascular reactivity to Bay K 8644 in genetic hypertension.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Inhibitory effect of 2,3-dibenzylbutane-1,4-diol; a mammalian lignan, on the CA2+ channel in rabbit femoral artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Effects of endothelins on nerve-mediated contractions of the mouse vas deferens.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Dihydropyridine-sensitive single calcium channels in airway smooth muscle cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Calcium dependence of the contraction produced by endothelin (ET-1) in isolated guinea-pig trachea.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Potentiating effect of daunorubicin on vasocontractile responses to KCl and BAY K 8644 in rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Differential effects of calcium antagonists and Bay K 8644 on contractile responses to exogenous noradrenaline and adrenergic nerve stimulation in the rabbit ear artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Deuterium oxide reduces agonist and depolarization-induced contraction of rat aortic rings.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Simultaneous measurement of membrane potential, cytosolic Ca2+, and tension in intact smooth muscles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Effects of a novel smooth muscle relaxant, KT-362, on contraction and cytosolic Ca2+ level in the rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
The inhibitory action of okadaic acid on mechanical responses in guinea-pig vas deferens.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Comparison of the effects of endothelin-1 and Bay k 8644 on twitch contractions of the field-stimulated rat vas deferens.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Contractions of dysgenic skeletal muscle triggered by a potentiated, endogenous calcium current.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Low pH-induced release of calcitonin gene-related peptide from capsaicin-sensitive sensory nerves: mechanism of action and biological response.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5 | 1991 |
Acetylcholine Ca2+ stores refilling directly involves a dihydropyridine-sensitive channel in dog trachea.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Effects of calcium-free solution, calcium antagonists, and the calcium agonist BAY K 8644 on mechanical responses of skeletal muscle from patients susceptible to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
BAY K 8644 and nifedipine alter halothane but not caffeine contractures of malignant hyperthermic muscle fibers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Effects of the calcium channel agonist, Bay K 8644, on the mechanical output of skeletal muscle fibers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Effects of BAY K 8644, nifedipine, and low Ca2+ on halothane and caffeine potentiation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Carbachol-induced nonspecific desensitization in guinea-pig ileum.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Use-dependent decline in rat aorta sensitivity to contraction by potassium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Omega conotoxin and prejunctional modulation of the biphasic response of the rat isolated urinary bladder to single pulse electrical field stimulation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Multiple effects of BAY K 8644 and nifedipine on isolated diaphragmatic fibers in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
The dual effect of BAY K 8644 on excitation-contraction coupling in gastric smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Sialic acid removal modulates the myocardial and vascular activity of calcium channel ligands.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Neurogenic function of the diabetic rat bladder: alteration by calcium channel effectors.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Indolizinsulphones. A class of blockers with dual but discriminative effects on L-type Ca2+ channel activity and excitation-contraction coupling in skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Sodium pump activity and contractile effect of ouabain in human placental veins.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Calcium antagonistic properties of the sesquiterpene T-cadinol: a comparison with nimodipine in the isolated rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Contraction of vascular smooth muscle induced by phorbol 12,13 dibutyrate in human and rat pulmonary arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Phorbol esters induce oscillatory contractions of intestinal smooth muscles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Synergistic coronary vasoconstriction produced by endothelin-1 in combination with 5-hydroxytryptamine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Nitrendipine potentiates Bay k 8644-induced contraction of isolated porcine coronary artery: evidence for functionally distinct dihydropyridine receptor subtypes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Excitation contraction coupling in skeletal muscle: evidence for a role of slow Ca2+ channels using Ca2+ channel activators and inhibitors in the dihydropyridine series.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
The effect of Bay K 8644 on contraction mediated by alpha-adrenoceptors in the rat saphenous vein.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Comparison of effects of a new dihydropyridine, Bay K 8644, and nifedipine on spontaneous mechanical activity in rat portal vein.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Positive inotropic effect of Bay K 8644: cAMP-independence and lack of inhibitory effect of adenosine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
The effects of BAY-K-8644 on the contraction of cat middle cerebral and femoral arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Further examination of the inhibitory actions of alpha 1-adrenoceptor agonists in rat vas deferens.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
The effect of the calcium channel agonist, Bay K-8644 on human vascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Inhibitory effect of adenosine on electrically evoked contractions in the rat vas deferens: calcium dependence.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
The effects of the dihydropyridine Bay K 8644 in guinea-pig isolated trachealis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Plasma membrane calcium flux, protein kinase C activation and smooth muscle contraction.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Activation of tracheal smooth muscle contraction: synergism between Ca2+ and activators of protein kinase C.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
A comparison of effects of BAY K 8644 and CGP 28392, dihydropyridines with Ca agonistic properties, on spontaneous mechanical activity in rat portal vein: modification of effect by ultraviolet radiation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
[Synergism of the calcium reversal phenomenon of potassium depolarizing in the rat uterine muscle by Bay k-8644, a calcium agonist].
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
The facilitative actions of Bay K 8644 on norepinephrine and KCl-induced contractures of rabbit aortic rings.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Effects of Bay K 8644 and nifedipine on femoral arteries of spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Effects of Bay K 8644 on contraction of the human isolated bronchus and guinea-pig isolated trachea.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
The effects of Bay K 8644 and nifedipine on the neural responses of the rabbit ear artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
[Effects of a new 1,4-dihydropyridine, Bay K 8644, on smooth muscle organs isolated from the guinea pig].
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Mechanism of barium-induced contraction in the vascular smooth muscle of rabbit aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Involvement of calcium channels in the contractile activity of neurotensin but not acetylcholine: studies with calcium channel blockers and Bay K 8644 on the rat fundus.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
The effect of Bay K 8644 on angiotensin II-induced contractions of rabbit aortic strips.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Contractile effects of Bay k 8644, a dihydropyridine calcium agonist, on isolated femoral arteries from spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Bay K 8644 and acetylcholine: different interaction with calcium ions in the rat duodenal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
The calcium channel agonist BAY K8644 enhances the responsiveness of human airway muscle to KCl and histamine but not to carbachol.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Calcium antagonists inhibit positive chronotropic responses to alpha 1-adrenoceptor activation in rat isolated atria.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Ca2+ channel ligand sensitive responses to the phorbol ester 12-O-tetradecanoylphorbol 13-acetate in vascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Effects of calcium, calcium channel blockers and Bay K 8644 on contractions induced by muscarinic receptor stimulation of isolated bladder muscle from rabbit and man.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Benzodiazepine interactions at neuronal and smooth muscle Ca2+ channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Demonstration of alpha 2-adrenoceptor-mediated contraction in the isolated canine saphenous artery treated with Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Role of endothelium in magnesium-induced relaxation of rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Effects of norepinephrine on BAY K-8644-induced contraction in porcine coronary artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Effects of dihydropyridines on stress, myosin phosphorylation, and V0 in smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Measurement of cytoplasmic free Ca2+ concentration in rabbit aorta using the photoprotein, aequorin. Effect of atrial natriuretic peptide on agonist-induced Ca2+ signal generation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Dihydropyridine-sensitive Ca2+ channels and inositol phospholipid metabolism in ethanol physical dependence.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Effects of Bay K 8644 on the electrically evoked and KCl-evoked norepinephrine release and the corresponding contraction in isolated canine saphenous veins.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
[Two components of calcium-dependent potassium permeability coexist in the membrane of frog skeletal muscle].
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Opposite effects of Bay k 8644 and nicardipine on the inhibitory effect of Ca2+ on rat myometrium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Vascular responses to agonists in rat mesenteric artery from diabetic rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Decreased contractile response after exposure of the rat aorta to Db cAMP or IBMX.
Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifl | 1987 |
Effects of a phorbol ester on rat aortic contraction and calcium influx in the presence and absence of BAY k 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1987 |
Interaction between Bay-K-8644 and various relaxant agents on K+-depolarized contracture of guinea pig taenia coli.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Influence of endothelium on the response to calcium agonists, calcium, potassium and noradrenaline in rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Inhibitory effects of caffeine on contractions and calcium movement in vascular and intestinal smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Nifedipine and BAY K inhibit contraction independently from their action on calcium channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Sites of action of dihydropyridine drugs in the mouse hemidiaphragm muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Is airway hyperresponsiveness a smooth muscle abnormality?
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Altered effect of BAY K 8644 after exposure of the rat aorta to IBMX or Db cAMP.
Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifl | 1988 |
Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Effects of extracellular calcium concentration and dihydropyridines on contraction in mammalian skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Bay K 8644-like contractile effects of a peptide isolated from spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Interactions between phorbol esters and agents which increase cytosolic calcium in the guinea pig parenchymal strip: direct and indirect effects on the contractile response.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Endothelin and Ca++ agonist Bay K 8644: different vasoconstrictive properties.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Dependence of stress on cross-bridge phosphorylation in vascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Mechanisms of increased responses of the aorta to alpha-adrenoceptor agonists in streptozotocin-induced diabetic rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Tetrodotoxin-resistant contractions induced by electrical stimulation of bladder muscle from man, rabbit and rat.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Voltage and time dependency of calcium mediated phasic and tonic responses in rat vas deferens smooth muscle--the effect of some calcium agonist and antagonist agents.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Interactions of calcium antagonists and the calcium channel agonist Bay K 8644 on neurotransmission of the mouse isolated vas deferens.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Stimulation of voltage-dependent contractions by calcium channel activator Bay K 8644 in the human upper urinary tract in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Inhibition of the oxygen-induced contraction of the isolated human umbilical artery by indomethacin, flurbiprofen, aspirin and drugs modifying Ca2+ disposition.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Endothelin increases single-channel calcium currents in coronary arterial smooth muscle cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Bay K 8644-induced potentiation of the contractile response of rabbit iliac artery to caffeine in a Ca2+-free medium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Effects of verapamil and BAY K 8644 on the hypoxic contraction of the isolated human pulmonary artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Characterization of the effects of AHN 086, an irreversible ligand of "peripheral" benzodiazepine receptors, on contraction in guinea-pig atrial and ileal longitudinal smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Assessment in pig coronary artery of long-lasting and potent calcium antagonistic actions of the novel dihydropyridine derivative mepirodipine hydrochloride.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Effects of calcium-entry modulators on the biphasic neurogenic contractions in the circular muscle of guinea pig vas deferens.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Differential antagonism of the negative inotropic effect of gentamicin by calcium ions, Bay K 8644 and isoprenaline in canine ventricular muscle: comparison with cobalt ions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Effects of atrial natriuretic factor (ANF) on phenylephrine-triggered intra- and extracellular calcium dependent contraction in rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Pharmacology of endothelin-1 in isolated vessels: effect of nicardipine, methylene blue, hemoglobin, and gossypol.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Endothelin-1-induced vascular contractions: interactions with drugs affecting the calcium channel.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Inhibition by prostaglandin E2 of neurotransmission in rabbit but not human bronchus--a calcium-related mechanism?
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Bay K 8644 induced necrosis in murine skeletal muscle in vitro: myofibre breakdown precedes significant alterations of intracellular [Ca] or pH.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Endothelin-1 contracts isolated vessels independently of dihydropyridine-sensitive Ca2+ channel activation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Sensitization alters contractile responses and calcium influx in human airway smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Vascular smooth muscle function in rats with acute renal failure.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Appearance of the slow Ca conductance in myotubes from mutant mice with "muscular dysgenesis".
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Regulation by calcium and myosin phosphorylation of the development and maintenance of stress in vascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Slow onset of and recovery from Ca blocking action of benidipine in rat aorta and portal vein.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Endothelin-induced contractions of tracheal smooth muscle and identification of specific endothelin binding sites in the trachea of the rat.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Outward potassium currents in freshly isolated smooth muscle cell of dog coronary arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
The selective potentiation of noradrenaline-induced tone by Bay K 8644 in the rabbit basilar artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Protein kinase C potentiates stretch-induced cerebral artery tone by increasing intracellular sensitivity to Ca2+.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Multiple sources of calcium for contraction of the human urinary bladder muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Effects of the Ca agonists Bay K 8644 and CGP 28392 on vascular smooth muscle tone.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Dihydropyridine inhibition of single calcium channels and contraction in rabbit mesenteric artery depends on voltage.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
[Effects of BAY K 8644, a slow calcium channel agonist, on muscle contraction induced by halothane in sensitive subjects with malignant hyperthermia].
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Potentiating effect of Bay K 8644 on the noradrenaline-induced contraction in rabbit renal and femoral arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Further investigation of a potential calcium channel modulator isolated from rat erythrocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Potentiation by treatment with reserpine of alpha 2-adrenoceptor-mediated contractions of rat tail artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
(-)-Bay K 8644 liberates a contractant factor from the endothelium of the rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Effects of Ca2+ antagonists and K+-channel activators on K+-induced contractions in the rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Relationship between myoplasmic calcium transients and calcium currents in frog skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Comparison of the effects of calcium and the calcium channel stimulant Bay k 8644 on neomycin-induced neuromuscular blockade.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Nicardipine inhibits axon conduction but causes dual changes of acetylcholine release in the mouse motor nerve.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Amplifying effects of several vasoconstrictor agents of alpha 1-adrenoceptor-mediated contraction of isolated thoracic aortae of the guinea pig.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1989 |
Role of endothelium in the contractile response of rat aorta to alpha-adrenoceptor agonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
A novel 1,4 dihydropyridine, BAY K 8644, with contractile effects on vascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Competitive interactions between Bay K 8644 and nifedipine in K+ depolarized smooth muscle: a passive role for Ca2+?
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |